Bleichmar Fonti & Auld LLP has launched a securities fraud investigation into Gildan Activewear Inc. (NYSE: GIL) following an 18.75% plunge in the company’s stock price on June 16, 2026. The decline, which erased $11.62 per share from a closing price of $61.97 to $50.35, was triggered by a report from Jehoshaphat Research alleging that Gildan artificially inflated revenues through aggressive channel stuffing. This legal scrutiny intensifies pressure on the apparel manufacturer to address claims that its reported growth metrics were unsustainable and misleading to investors.

The investigation centers on allegations that Gildan misled shareholders about the true drivers of its financial results. While management attributed strong sales to "share gains in key growth categories" and "strong market response to products," the short seller report contends these figures were fabricated by pulling forward future demand. According to the report, titled "Stuffing All of the Channel Some of the Time?", Gildan’s practices have been cannibalizing future demand and inflating the overall growth trajectory of the business. These findings are based on interviews with former employees, customers, and distributors.

Legal Landscape and Market Reaction

The market reaction to the June 16, 2026, report was immediate and severe, signaling deep investor skepticism regarding the sustainability of Gildan’s sales model. The stock drop underscores the risk associated with revenue recognition practices that rely on channel loading rather than organic demand. Bleichmar Fonti & Auld LLP is examining whether these practices constitute securities fraud, potentially offering recovery options for shareholders who incurred losses during this period.

This investigation adds to a growing list of legal actions against Gildan. Robbins LLP previously filed a class action lawsuit on behalf of former HanesBrands Inc. shareholders who acquired Gildan shares during the December 2025 cash-and-stock exchange. Additionally, Rosen Law Firm announced its own investigation on July 20, 2026, focusing on similar misrepresentation claims. The convergence of multiple law firms indicates robust legal pressure on Gildan to clarify its operational realities.

What the Numbers Show

The allegation that Gildan engaged in channel stuffing suggests a significant divergence between reported top-line growth and underlying cash flow health. If sales are being pulled forward to meet quarterly targets, Days of Sales Outstanding likely reached peak levels, indicating working capital strain. For investors, the 18.75% single-day loss represents a sharp repricing of risk, reflecting doubts that previous earnings were driven by legitimate market share gains or product innovation. The multi-firm legal involvement further complicates Gildan’s outlook, as potential liabilities could impact future capital allocation and shareholder value.

Gildan Activewear expects to receive $220 million in IEEPA tariff refunds through the U.S. Customs and Border Protection (CBP) refund process in 2026, providing a significant financial boost that will be partially reinvested into strategic growth initiatives. The majority of these refunds are anticipated to be recorded during the third quarter of 2026, offering immediate liquidity and capital allocation flexibility for the apparel manufacturer.

The company has categorized the anticipated refunds into two distinct components: non-recurring benefits and recurring structural benefits. A significant portion of the $220 million represents a one-time gain that Gildan plans to reinvest directly into new incremental strategic growth initiatives for 2026. These investments will target brand building, retail marketing programs, and the acceleration of product innovation and packaging enhancements.

Conversely, a sizeable portion of the refunds reflects a recurring benefit driven by recent changes to U.S. tariff policy. Tariffs have ceased to apply on apparel qualifying as originating under the Dominican Republic-Central America Free Trade Agreement (CAFTA-DR). This regulatory shift represents a structural benefit for the company going forward, improving long-term margin profiles for qualifying products.

Financial Impact and Allocation

The impact of this recurring structural benefit is already reflected in the company’s updated financial guidance, signaling sustained profitability improvements beyond the initial refund receipt. The separation of non-recurring and recurring elements allows investors to distinguish between temporary cash inflows and permanent cost structure improvements.

What the Numbers Show

The bifurcation of the $220 million refund highlights a dual-value creation strategy. While the non-recurring portion provides discretionary capital for aggressive growth levers such as marketing and R&D, the recurring portion validates the efficacy of Gildan’s supply chain positioning under CAFTA-DR. This structural advantage suggests that future earnings power is enhanced independently of the one-time cash injection, as the removal of tariffs on qualifying apparel permanently lowers the cost base for those specific product lines.